This article contains noninclusive language such as "females" and "women" when those terms were used in the research and historic context we are summarizing. New therapies have become available for vasomotor symptoms, postpartum depression, contraception, osteoporosis, recurrent yeast infections, acute and recurrent urinary tract infections, and female hypoactive sexual desire disorder. These therapies meet unique patient needs and change clinical practice for select groups. As is typical for new treatments, insurance coverage and access issues limit the adoption of some therapies.
Keywords: Contraception; Hypoactive sexual desire disorder; Menopause; Osteoporosis; Postpartum depression; Urinary tract infection; Vulvovaginal candidiasis; Women’s health.
Copyright © 2024 Elsevier Inc. All rights reserved.